Yeaman Kevin J's Form 4 filing
Dolby Laboratories, Inc. (DLB) · filed Dec 17, 2025
- Accession no.
- 0001193125-25-323431
- Filed
- Dec 17, 2025
- Trade date
- Dec 15-17, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.24M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yeaman Kevin JCIK 0001200469 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Class A Common Stock | AGrant or awardAcquired | +65,968 | $0.00 | $0 | 193,703 | Direct | |
| Dec 15, 2025 | Class A Common Stock | MOption exerciseAcquired | +17,633 | $0.00F3 | $0 | 202,587 | Direct | |
| Dec 15, 2025 | Class A Common Stock | FTax withholdingDisposed | −27,180 | $67.54 | −$1,835,737.2 | 157,390 | Direct | |
| Dec 16, 2025 | Class A Common Stock | FTax withholdingDisposed | −6,855 | $66.62 | −$456,680.1 | 143,784 | Direct | |
| Dec 16, 2025 | Class A Common Stock | SSaleDisposed | −21,772 | $66.64F8 | −$1,450,886.08 | 110,122 | Indirect | |
| Dec 16, 2025 | Class A Common Stock | SSaleDisposed | −4,994 | $67.16F11 | −$335,397.04 | 105,128 | Indirect | |
| Dec 17, 2025 | Class A Common Stock | SSaleDisposed | −6,671 | $67.24F12 | −$448,558.04 | 98,457 | Indirect | |
| Dec 17, 2025 | Class A Common Stock | SSaleDisposed | −80 | $67.54 | −$5,403.2 | 98,377 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Class A Common Stock | AGrant or awardAcquired | +32,984 | $0.00 | $0 | 32,984 | Direct | |
| Dec 15, 2025 | Class A Common Stock | AGrant or awardAcquired | +145,252 | $0.00 | $0 | 145,252 | Direct | |
| Dec 15, 2025 | Class A Common Stock | MOption exerciseDisposed | −17,633 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock.
Referenced by the price of 1 transaction in Table I.
- F8
The shares were sold in multiple transactions at prices ranging from $65.98 to $66.975, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025.
Referenced by the price of 1 transaction in Table I.
- F11
The shares were sold in multiple transactions at prices ranging from $67.00 to $67.375, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025.
Referenced by the price of 1 transaction in Table I.
- F12
The shares were sold in multiple transactions at prices ranging from $66.49 to $67.48, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025.
Referenced by the price of 1 transaction in Table I.